Michael Savona

Among those honored at last week’s event were (front row, from left) Pratik Pandharipande, MD, MSCI, Seth Smith, PhD, Kimberly Vinson, MD, Jessica Ancker, PhD, MPH, Nancy Davis, MD, Uyen Tran, MD, Tonia Rex, PhD, Adam Yock, PhD, DABR, Christopher Williams, MD, PhD, David Raiford, MD, (back row, from left) Adam Wright, PhD, Paul Moore, MD, Daniel Fabbri, PhD, John Penn, PhD, Rebecca Swan, MD, Alexander Gelbard, MD, Jennifer Lindsey, MD, Michael Savona, MD, Kathryn Lindley, MD, Sarah Jaser, PhD, and Douglas Johnson, MD, MSCI.
September 8, 2022

Directorships honor VUMC leaders and philanthropic partners

By Doug Campbell
March 7, 2022

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease

By Tom Wilemon
May 6, 2021

IMPACT research grants to help underserved patients access clinical trials

The Leukemia & Lymphoma Society (LLS) announced today the launch of IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Vanderbilt University Medical Center is leading one of the first three projects to receive IMPACT funding.

By VUMC News and Communications
April 20, 2021

New therapeutic strategy for leukemia syndrome

Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.

By Leigh MacMillan
March 25, 2021

Eight named to hold VUMC endowed directorships

Eight leaders from across Vanderbilt University Medical Center have been named as holders of endowed directorships.

By Nancy Humphrey
September 24, 2020

VICC leading first global study of MDS/MPN overlap syndrome

Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).

By Tom Wilemon
March 5, 2020

One-two punch for cancer

A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.
By Sanjay Mishra
August 1, 2019

Grant bolsters research on myelodysplastic syndromes

Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
By Tom Wilemon
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
By VUMC News and Communications